MedTech Dive July 16, 2024
Nick Paul Taylor

The changes are part of a broader reorganization intended to increase organizational agility and help the agency meet user fee commitments.

Dive Brief:

  • The Food and Drug Administration said Monday it has reorganized the Center for Devices and Radiological Health.
  • FDA officials have restructured offices focused on communication and clinical evidence, creating a new division and turning an existing group into a “super office.”
  • The FDA said the changes are intended to help the agency meet its Medical Device User Fee Amendments (MDUFA) V commitments and strategic priorities.

Dive Insight:

The FDA has restructured its drug and device operations in recent years to support its work to meet user fee goals. On the device side, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Medical Devices
Related Articles:
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article